JP2022529371A5 - - Google Patents
Info
- Publication number
- JP2022529371A5 JP2022529371A5 JP2021562812A JP2021562812A JP2022529371A5 JP 2022529371 A5 JP2022529371 A5 JP 2022529371A5 JP 2021562812 A JP2021562812 A JP 2021562812A JP 2021562812 A JP2021562812 A JP 2021562812A JP 2022529371 A5 JP2022529371 A5 JP 2022529371A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- alkyl
- group
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962837827P | 2019-04-24 | 2019-04-24 | |
| US62/837,827 | 2019-04-24 | ||
| PCT/US2020/029466 WO2020219640A1 (en) | 2019-04-24 | 2020-04-23 | Pyrimidine jak inhibitors for the treatment of skin diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022529371A JP2022529371A (ja) | 2022-06-21 |
| JP2022529371A5 true JP2022529371A5 (https=) | 2023-04-04 |
| JP7482152B2 JP7482152B2 (ja) | 2024-05-13 |
Family
ID=70779856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021562812A Active JP7482152B2 (ja) | 2019-04-24 | 2020-04-23 | 皮膚疾患の処置のためのピリミジンｊａｋ阻害剤 発明の背景 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11439641B2 (https=) |
| EP (1) | EP3959213B1 (https=) |
| JP (1) | JP7482152B2 (https=) |
| AR (1) | AR118767A1 (https=) |
| CA (1) | CA3135388A1 (https=) |
| ES (1) | ES2994097T3 (https=) |
| HR (1) | HRP20241053T1 (https=) |
| HU (1) | HUE067909T2 (https=) |
| PL (1) | PL3959213T3 (https=) |
| TW (1) | TW202106681A (https=) |
| WO (1) | WO2020219640A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202001706RA (en) | 2017-10-27 | 2020-03-30 | Theravance Biopharma R&D Ip Llc | Pyrimidine compound as jak kinase inhibitor |
| WO2020108613A1 (zh) * | 2018-11-30 | 2020-06-04 | 江苏豪森药业集团有限公司 | 杂芳类衍生物调节剂、其制备方法和应用 |
| PL3958969T3 (pl) | 2019-04-24 | 2024-05-20 | Theravance Biopharma R&D Ip, Llc | Estrowe i węglanowe związki pirymidynowe jako inhibitory kinaz |
| CN116390922B (zh) * | 2020-10-21 | 2025-07-18 | 珠海联邦制药股份有限公司 | 硒杂环类化合物及其应用 |
| WO2022094174A1 (en) * | 2020-10-30 | 2022-05-05 | Children's Hospital Medical Center | Compositions and methods for the treatment of esophageal conditions |
| JP2024516299A (ja) * | 2021-05-03 | 2024-04-12 | インサイト・コーポレイション | 結節性痒疹の治療のためのルキソリチニブ |
| UA129643C2 (uk) | 2021-05-03 | 2025-06-18 | Інсайт Корпорейшн | Інгібітори шляху jak1 для лікування вузлуватого свербця |
| WO2023202706A1 (zh) * | 2022-04-21 | 2023-10-26 | 南京明德新药研发有限公司 | 硒杂环类化合物的盐型和晶型及其应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4919934A (en) | 1989-03-02 | 1990-04-24 | Richardson-Vicks Inc. | Cosmetic sticks |
| US6660731B2 (en) | 2000-09-15 | 2003-12-09 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| WO2002022605A1 (en) | 2000-09-15 | 2002-03-21 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| US6989385B2 (en) | 2000-12-21 | 2006-01-24 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| US20070179125A1 (en) | 2005-11-16 | 2007-08-02 | Damien Fraysse | Aminopyrimidines useful as kinase inhibitors |
| TW200817391A (en) | 2006-06-30 | 2008-04-16 | Astrazeneca Ab | Novel compounds |
| EP2043651A2 (en) | 2006-07-05 | 2009-04-08 | Exelixis, Inc. | Methods of using igf1r and abl kinase modulators |
| CN104011050A (zh) | 2011-12-22 | 2014-08-27 | 霍夫曼-拉罗奇有限公司 | 作为丝氨酸/苏氨酸激酶抑制剂的2,4-二氨基-嘧啶衍生物 |
| WO2015094803A1 (en) | 2013-12-16 | 2015-06-25 | Calitor Sciences, Llc | Substituted heteroaryl compounds and methods of use |
| NO2721710T3 (https=) | 2014-08-21 | 2018-03-31 | ||
| ES2753159T3 (es) | 2015-05-28 | 2020-04-07 | Theravance Biopharma R&D Ip Llc | Compuestos de naftiridina como inhibidores de quinasa JAK |
| CA3020506A1 (en) | 2016-04-28 | 2017-11-02 | Theravance Biopharma R&D Ip, Llc | Pyrimidine compounds as jak kinase inhibitors |
| CN106588885B (zh) * | 2016-11-10 | 2019-03-19 | 浙江大学 | 2-取代芳环-嘧啶类衍生物及制备和应用 |
| SG11202001706RA (en) | 2017-10-27 | 2020-03-30 | Theravance Biopharma R&D Ip Llc | Pyrimidine compound as jak kinase inhibitor |
| WO2020108516A1 (zh) | 2018-11-27 | 2020-06-04 | 江苏豪森药业集团有限公司 | 含氮杂芳类衍生物调节剂、其制备方法和应用 |
| WO2020108613A1 (zh) | 2018-11-30 | 2020-06-04 | 江苏豪森药业集团有限公司 | 杂芳类衍生物调节剂、其制备方法和应用 |
| PL3958969T3 (pl) * | 2019-04-24 | 2024-05-20 | Theravance Biopharma R&D Ip, Llc | Estrowe i węglanowe związki pirymidynowe jako inhibitory kinaz |
| CN113372364B (zh) | 2020-03-10 | 2024-05-31 | 明慧医药（上海）有限公司 | 一类jak激酶抑制剂及其制备和应用 |
| CN113372351A (zh) | 2020-03-10 | 2021-09-10 | 明慧医药（杭州）有限公司 | 一类jak激酶抑制剂及其制备和应用 |
-
2020
- 2020-04-23 TW TW109113573A patent/TW202106681A/zh unknown
- 2020-04-23 WO PCT/US2020/029466 patent/WO2020219640A1/en not_active Ceased
- 2020-04-23 HR HRP20241053TT patent/HRP20241053T1/hr unknown
- 2020-04-23 US US16/856,283 patent/US11439641B2/en active Active
- 2020-04-23 HU HUE20727424A patent/HUE067909T2/hu unknown
- 2020-04-23 ES ES20727424T patent/ES2994097T3/es active Active
- 2020-04-23 EP EP20727424.2A patent/EP3959213B1/en active Active
- 2020-04-23 PL PL20727424.2T patent/PL3959213T3/pl unknown
- 2020-04-23 CA CA3135388A patent/CA3135388A1/en active Pending
- 2020-04-23 AR ARP200101151A patent/AR118767A1/es not_active Application Discontinuation
- 2020-04-23 JP JP2021562812A patent/JP7482152B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022529371A5 (https=) | ||
| JP2022529370A5 (https=) | ||
| RU2353616C2 (ru) | Производные 2-пиридона в качестве ингибиторов эластазы нейтрофилов и их применение | |
| KR101694383B1 (ko) | 이미다조피롤리디논 화합물 | |
| AU2016368317B2 (en) | Inhibitors of influenza virus replication, application methods and uses thereof | |
| JP2021524842A5 (https=) | ||
| JP2012524053A5 (https=) | ||
| RU2011121567A (ru) | Изоиндолиновые соединения для применения при лечении рака | |
| RU2006112427A (ru) | Производные 2-пиридона в качестве ингибиторов эластазы нейтрофилов и их применение | |
| KR20170094263A (ko) | Ｎａｄｐｈ 옥시다제 억제제인 아미도 티아디아졸 유도체 | |
| JP2020510015A5 (https=) | ||
| RU2012135698A (ru) | Способ и композиция | |
| JP2024531694A (ja) | Ａｈｒアゴニスト | |
| WO2015161830A1 (en) | Heteroaromatic derivatives and pharmaceutical applications thereof | |
| JP2018536678A (ja) | セフェム系化合物、それらの生成および使用 | |
| EA030374B1 (ru) | Производные нафтиридиндиона | |
| RU2010132911A (ru) | Гидроксилированные пиримидилциклопентаны в качестве ингибиторов протеинкиназы (акт) | |
| US20230029009A1 (en) | Chemical compounds | |
| JP2024069223A5 (https=) | ||
| US20170007615A1 (en) | Antibacterial Compounds | |
| RU2018130097A (ru) | Лечение экземы кистей | |
| US11932639B2 (en) | Fused ring heteroaryl compounds as ALK4/5 inhibitors | |
| WO2024050434A1 (en) | ISOQUINOLINE COMPOUNDS AND THEIR USE IN TREATING AhR MEDIATED DISEASES | |
| RU2010132230A (ru) | Производные 2-гетероароилимидазо[1,2-а] пиридина, способ их получения и применение их в терапии | |
| WO2015179697A1 (en) | Compounds for the treatment of bacterial infections |